NO20032573L - Nye difibroblastvekstfaktorer - Google Patents
Nye difibroblastvekstfaktorerInfo
- Publication number
- NO20032573L NO20032573L NO20032573A NO20032573A NO20032573L NO 20032573 L NO20032573 L NO 20032573L NO 20032573 A NO20032573 A NO 20032573A NO 20032573 A NO20032573 A NO 20032573A NO 20032573 L NO20032573 L NO 20032573L
- Authority
- NO
- Norway
- Prior art keywords
- difibroblast
- new
- growth factors
- growth
- factors
- Prior art date
Links
- 239000003102 growth factor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25183700P | 2000-12-08 | 2000-12-08 | |
US10/005,646 US20020151496A1 (en) | 2000-12-08 | 2001-12-07 | Novel fibroblast growth factors |
PCT/US2001/047350 WO2002046424A2 (en) | 2000-12-08 | 2001-12-10 | Fibroblast growth factors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20032573D0 NO20032573D0 (no) | 2003-06-06 |
NO20032573L true NO20032573L (no) | 2003-07-22 |
Family
ID=26674594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20032573A NO20032573L (no) | 2000-12-08 | 2003-06-06 | Nye difibroblastvekstfaktorer |
Country Status (21)
Country | Link |
---|---|
US (2) | US20020151496A1 (no) |
EP (1) | EP1389237A2 (no) |
JP (1) | JP2005506275A (no) |
KR (1) | KR20040052442A (no) |
CN (1) | CN1518597A (no) |
AU (1) | AU2603402A (no) |
BG (1) | BG107888A (no) |
BR (1) | BR0116507A (no) |
CA (1) | CA2431374A1 (no) |
CZ (1) | CZ20031570A3 (no) |
EE (1) | EE200300269A (no) |
HU (1) | HUP0400657A1 (no) |
IL (1) | IL156259A0 (no) |
MX (1) | MXPA03005142A (no) |
NO (1) | NO20032573L (no) |
PL (1) | PL366158A1 (no) |
RU (1) | RU2329058C2 (no) |
SI (1) | SI21372A (no) |
SK (1) | SK7012003A3 (no) |
WO (1) | WO2002046424A2 (no) |
ZA (1) | ZA200305236B (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7253266B2 (en) | 1999-07-27 | 2007-08-07 | Curagen Corporation | Polypeptides of FGF-CX |
US7189693B2 (en) | 2000-11-06 | 2007-03-13 | Curagen Corporation | Treatment of inflammatory bowel disease using fibroblast growth factor CX polypeptides |
US6982250B2 (en) | 2000-11-06 | 2006-01-03 | Curagen Corporation | Methods of prevention and treatment of inflammatory bowel disease |
US20050176631A1 (en) * | 2002-01-15 | 2005-08-11 | Heuer Josef G. | Method for reducing morbidity and mortality in critically ill patients |
CA2521217C (en) | 2003-04-01 | 2013-05-14 | United States Of America Department Of Veteran's Affairs | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
WO2004105787A1 (en) * | 2003-05-28 | 2004-12-09 | The University Of Kyoto | Methods of using combinations of egf-2 and egf-20 to treat central nervous system disorders |
KR102077721B1 (ko) | 2011-07-01 | 2020-02-14 | 엔지엠 바이오파마슈티컬스, 아이엔씨. | 대사성 장애 및 질환의 치료를 위한 조성물, 용도 및 방법 |
US9290557B2 (en) | 2012-11-28 | 2016-03-22 | Ngm Biopharmaceuticals, Inc. | Compositions comprising variants and fusions of FGF19 polypeptides |
NZ630484A (en) | 2012-11-28 | 2017-04-28 | Ngm Biopharmaceuticals Inc | Compositions and methods for treatment of metabolic disorders and diseases |
US9273107B2 (en) | 2012-12-27 | 2016-03-01 | Ngm Biopharmaceuticals, Inc. | Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases |
KR20230164238A (ko) | 2012-12-27 | 2023-12-01 | 엔지엠 바이오파마슈티컬스, 아이엔씨. | 담즙산 항상성의 조절 및 담즙산 질환 및 질병의 치료 방법 |
KR102178945B1 (ko) | 2013-10-28 | 2020-11-13 | 엔지엠 바이오파마슈티컬스, 아이엔씨. | 암 모델 및 관련 방법 |
HUE050279T2 (hu) | 2014-01-24 | 2020-11-30 | Ngm Biopharmaceuticals Inc | Béta-klotho 2-es doménjéhez kötõdõ antitestek és azok alkalmazási módszerei |
WO2015183890A2 (en) | 2014-05-28 | 2015-12-03 | Ngm Biopharmaceuticals, Inc. | Methods and compositions for the treatment of metabolic disorders and diseases |
AU2015277438B2 (en) | 2014-06-16 | 2020-02-27 | Ngm Biopharmaceuticals, Inc. | Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases |
JP6949711B2 (ja) | 2014-10-23 | 2021-10-20 | エヌジーエム バイオファーマシューティカルス,インコーポレーテッド | ペプチドバリアントを含む医薬組成物及びその使用方法 |
US10434144B2 (en) | 2014-11-07 | 2019-10-08 | Ngm Biopharmaceuticals, Inc. | Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders |
US10800843B2 (en) | 2015-07-29 | 2020-10-13 | Ngm Biopharmaceuticals, Inc. | Beta klotho-binding proteins |
ES2871036T3 (es) | 2015-11-09 | 2021-10-28 | Ngm Biopharmaceuticals Inc | Método para el tratamiento de trastornos relacionados con ácidos biliares |
AU2017315459B2 (en) | 2016-08-26 | 2023-06-29 | Ngm Biopharmaceuticals, Inc. | Methods of treating fibroblast growth factor 19-mediated cancers and tumors |
CN107050428B (zh) * | 2017-03-23 | 2020-05-05 | 温州医科大学 | Fgf20药物及其对脑创伤的治疗应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3924300A (en) * | 1999-04-02 | 2000-10-23 | Millennium Pharmaceuticals, Inc. | Fibroblast growth factor-20 |
EP1224283A2 (en) * | 1999-10-22 | 2002-07-24 | Chiron Corporation | Human and rat fgf-20 genes and gene expression products |
AU1922101A (en) * | 1999-11-18 | 2001-05-30 | Chiron Corporation | Human fgf-21 gene and gene expression products |
WO2001092522A2 (en) * | 2000-06-01 | 2001-12-06 | Eli Lilly And Company | Human fgf-20 nucleic acids and polypeptides |
AU2001271811B2 (en) * | 2000-07-03 | 2006-07-20 | Curagen Corporation | Novel fibroblast growth factors and nucleic acids encoding same |
-
2001
- 2001-12-07 US US10/005,646 patent/US20020151496A1/en not_active Abandoned
- 2001-12-10 EP EP01995460A patent/EP1389237A2/en active Pending
- 2001-12-10 CZ CZ20031570A patent/CZ20031570A3/cs unknown
- 2001-12-10 SK SK701-2003A patent/SK7012003A3/sk unknown
- 2001-12-10 BR BR0116507-0A patent/BR0116507A/pt not_active IP Right Cessation
- 2001-12-10 HU HU0400657A patent/HUP0400657A1/hu unknown
- 2001-12-10 KR KR10-2003-7007614A patent/KR20040052442A/ko not_active Application Discontinuation
- 2001-12-10 SI SI200120066A patent/SI21372A/sl not_active IP Right Cessation
- 2001-12-10 AU AU2603402A patent/AU2603402A/xx active Pending
- 2001-12-10 CA CA002431374A patent/CA2431374A1/en not_active Abandoned
- 2001-12-10 JP JP2002548141A patent/JP2005506275A/ja active Pending
- 2001-12-10 IL IL15625901A patent/IL156259A0/xx unknown
- 2001-12-10 MX MXPA03005142A patent/MXPA03005142A/es not_active Application Discontinuation
- 2001-12-10 EE EEP200300269A patent/EE200300269A/xx unknown
- 2001-12-10 CN CNA018202993A patent/CN1518597A/zh active Pending
- 2001-12-10 PL PL01366158A patent/PL366158A1/xx not_active Application Discontinuation
- 2001-12-10 WO PCT/US2001/047350 patent/WO2002046424A2/en active IP Right Grant
- 2001-12-10 RU RU2003119657/14A patent/RU2329058C2/ru not_active IP Right Cessation
-
2003
- 2003-06-06 BG BG107888A patent/BG107888A/bg unknown
- 2003-06-06 NO NO20032573A patent/NO20032573L/no not_active Application Discontinuation
- 2003-07-07 ZA ZA2003/05236A patent/ZA200305236B/en unknown
-
2007
- 2007-06-22 US US11/821,191 patent/US20080057076A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2005506275A (ja) | 2005-03-03 |
KR20040052442A (ko) | 2004-06-23 |
CZ20031570A3 (cs) | 2004-01-14 |
WO2002046424A2 (en) | 2002-06-13 |
ZA200305236B (en) | 2005-06-29 |
IL156259A0 (en) | 2004-01-04 |
BR0116507A (pt) | 2004-01-06 |
SK7012003A3 (en) | 2004-04-06 |
NO20032573D0 (no) | 2003-06-06 |
HUP0400657A1 (en) | 2006-04-28 |
US20080057076A1 (en) | 2008-03-06 |
EE200300269A (et) | 2003-10-15 |
MXPA03005142A (es) | 2004-10-15 |
AU2002226034A2 (en) | 2002-06-18 |
PL366158A1 (en) | 2005-01-24 |
CN1518597A (zh) | 2004-08-04 |
SI21372A (sl) | 2004-06-30 |
EP1389237A2 (en) | 2004-02-18 |
WO2002046424A3 (en) | 2003-11-27 |
BG107888A (bg) | 2004-08-31 |
CA2431374A1 (en) | 2002-06-13 |
RU2003119657A (ru) | 2005-02-27 |
AU2603402A (en) | 2002-06-18 |
US20020151496A1 (en) | 2002-10-17 |
RU2329058C2 (ru) | 2008-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20026064L (no) | Nye forbindelser | |
NO20023934L (no) | Nye forbindelser | |
NO20032573L (no) | Nye difibroblastvekstfaktorer | |
NO20035428D0 (no) | Nye anti-ineffektiver | |
NO20034992D0 (no) | Nye 4-aninlinokinolin-3-karboksamider | |
IS6492A (is) | Ný bíarýlkarboxamíð | |
DK1292733T3 (da) | Kunstplæne | |
DK1333853T3 (da) | Vækstfaktorkompleks | |
NO20020810D0 (no) | Nye fenylpiperaziner | |
DK1344773T3 (da) | Væksthormonsekretionsfremmere | |
NO20025151D0 (no) | Nye forbindelser | |
NO20031141D0 (no) | Nye forbindelser | |
NO20026162L (no) | Nye forbindelser | |
NO20041185L (no) | Nye sykloheksylsulfoner | |
NO20030274L (no) | Nye aryleten-sulfonamider | |
NO20026081D0 (no) | Nye forbindelser | |
NO20026086L (no) | Transgent produsert plateavledet vekstfaktor | |
NO20013601D0 (no) | Nye morfolinobenzamidsalter | |
NO20025902L (no) | Nye fenylpiperaziner | |
DK1246934T3 (da) | Mikrobielle vækstvariationer | |
FI20001470A (fi) | Kasvuallas | |
SE0003158D0 (sv) | Odlingsanordning | |
DE60133669D1 (de) | Insulinähnlichen wachstumsfaktors 1 | |
FI4625U1 (fi) | Tuulikukka | |
NO20006308D0 (no) | Dyrkingskjegle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |